IM Cannabis (IMCC) Gross Profit Growth (3y) (2023 - 2026)
IM Cannabis (IMCC) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 0.95% |
| 10 | IM Cannabis | 525,798.39 | -206,324.13 | 1.03 Mn | -21.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.61% |
| Dec 31, 2025 | -68.70% |
| Sep 30, 2025 | 9.84% |
| Jun 30, 2025 | 12.71% |
| Mar 31, 2025 | 8.17% |
| Dec 31, 2024 | 35.18% |
| Sep 30, 2024 | 244.07% |
| Jun 30, 2024 | 49.41% |
| Mar 31, 2024 | -30.73% |
| Dec 31, 2023 | 16.68% |
| Sep 30, 2023 | -8.04% |
| Jun 30, 2023 | 21.52% |
| Mar 31, 2023 | -14.40% |